Company Data

Summit Therapeutics Inc.

Ticker
SMMT
Current Price
$21.37 -2.06%
Market Cap
$15.8B
Price Target
Refer to Report
Volume
2.3M
52wk Range
$2.1 - $33.89
Advanced Market Data

Overview

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy